iiinova — where your digital self keeps evolving

Ingelfinger Lab @ingelfingerlab.bsky.social · 02/10/2026

Upcoming CRC1479 Seminar Felix Hartmann (DKFZ): “Spatial Quantification of Cellular Metabolic States in Human Cancer” 📅 9 Oct. 2026 🕐 1:00 pm CEST 📍 ZTZ, Breisacher Str. 115, 79106 Freiburg, Room 00.057/2 💻 Online: uniklinik-freiburg.webex.com/uniklinik-fr... Everyone is warmly invited to join!

011

Reposted by Ingelfinger Lab

Florian Ingelfinger @florianingelfinger.bsky.social · 01/10/2026

1/3 Deep generative modeling coming to cytometry! 🔬 CytoVI is now in Nature Methods: integrate flow cytometry, mass cytometry & CITE-seq, predict missing markers, and discover disease-associated cell states. www.nature.com/articles/s41...

nature.com

CytoVI: deep generative modeling of antibody-based single cell data - Nature Methods

CytoVI is a deep generative model for statistically rigorous analysis of antibody-based single-cell data.

193

Ingelfinger Lab @ingelfingerlab.bsky.social · 29/08/2026

Celebrating Pablo for successfully defending his masters thesis in our lab! Amazing work 🔥🔥🔥

041

Ingelfinger Lab @ingelfingerlab.bsky.social · 17/08/2026

Outside the lab: Powered by coffee (probably a little too much) Always up for a hike Badminton enthusiast, on and off the court Passionate home baker Welcome to our team Julia! Stay tuned to meet the rest of the Ingelfinger team!

010

Ingelfinger Lab @ingelfingerlab.bsky.social · 17/08/2026

These experiences sparked my fascination with the interplay between the immune system and cancer, ultimately leading me to pursue a PhD in cancer immunology.

110

Ingelfinger Lab @ingelfingerlab.bsky.social · 17/08/2026

During this time, I explored diverse aspects of immunology: From the role of the neonatal Fc receptor in viral infections during my Bachelor's thesis to the phenotypic and functional characterization of monocyte subsets in tumor pathogenesis in my Master's thesis.

100

Ingelfinger Lab @ingelfingerlab.bsky.social · 17/08/2026

What did I do before? I studied Medical Biology at the University of Duisburg-Essen while working as a student research assistant in the Lab of Prof. Karl Lang at the Institute of Immunology.

110

Ingelfinger Lab @ingelfingerlab.bsky.social · 17/08/2026

What am I working on? My PhD focuses on immune evasion in brain metastases. Using single-cell, spatial, and computational approaches, I aim to understand how metastatic tumors escape immune surveillance and how the brain microenvironment shapes anti-tumor immune responses.

100

Ingelfinger Lab @ingelfingerlab.bsky.social · 17/08/2026

Meet our team: Hi! I’m Julia :) I'm a PhD student in the Ingelfinger Lab, which I joined in May 2026. What drew me here was the exciting research project, the collaborative environment, and the opportunity to explore state-of-the-art technologies in cancer immunology.

130

Ingelfinger Lab @ingelfingerlab.bsky.social · 21/07/2026

This project was performed with Bettina Schreiner and the @becher and supported by many fantastic collaborators.

100

Ingelfinger Lab @ingelfingerlab.bsky.social · 26/06/2026

The beautiful Black Forest provided the perfect environment to exchange ideas, build new friendships, and explore exciting opportunities for future projects and collaborations. A special highlight was the keynote lecture by Daniel Kirschenbaum. Thank you for your amazing talk!

020

Ingelfinger Lab @ingelfingerlab.bsky.social · 26/06/2026

First-Ever Ingelhoeffheimer Retreat: Three Days of Science, breathtaking nature and Fun ✨️ We have just returned from the very first joint Scientific Retreat with the amazing members of the Hoefflin and Wertheimer labs.

150

Ingelfinger Lab @ingelfingerlab.bsky.social · 08/06/2026

We thank you for the appraisal of our work :)

110

Ingelfinger Lab @ingelfingerlab.bsky.social · 08/06/2026

hello world. Excited to launch the Ingelfinger Lab account! We’re a young lab in Germany’s Black Forest tackling key questions in immunology with innovative single-cell technologies. Follow us for updates on systems immunology, machine learning & translational oncology. fi

0165